FDARecall 100038Medicines
What to do
The FDA record of this recall has no instruction for consumers. Compare the lot codes below with your product. If they match, do not use it, and follow the notice of the firm or ask the store where you bought it. Talk to your pharmacist or doctor before stopping a medicine.Note from Recalls Watch, not agency text.
Read the official notice on accessdata.fda.gov (opens in a new tab)
Hazard
Why it was recalled
CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory
FDA classification: Class II. Use may cause temporary or medically reversible health consequences, or the chance of serious consequences is remote. Status: Ongoing.
Is it yours? Products and codes
Type the lot, batch, date code, model number or UPC printed on the product. It is compared here, in your browser, with the codes this notice lists. The code is also added to the page address (?lot=…), so a copied link or result carries it.
General information on recalls from the agency: U.S. Food and Drug Administration (opens in a new tab).
Theophylline Extended-Release Tablets, 100 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-500-10
- Lot or code
- Lot: 405617, Expiry: 03/31/2028
- FDA recall number
- D-0110-2027
- Quantity
- 1,620 100-count bottles
Theophylline Extended-Release Tablets, 200 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-501-10.
- Lot or code
- Lot: 405620, Expiry: 03/31/2028.
- FDA recall number
- D-0111-2027
- Quantity
- 1,332 100-count bottles
Distribution (FDA): Nationwide within U.S
About this record
- Issued by
- U.S. Food and Drug Administration
- Firm
- Brandywine Pharmaceuticals, LLC
- Title
- Composed by Recalls Watch from fields of the record; FDA records have no title.